{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:23:07Z","timestamp":1786990987514,"version":"build-2736575974"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T00:00:00Z","timestamp":1720051200000},"content-version":"vor","delay-in-days":185,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/T024054\/1"],"award-info":[{"award-number":["MR\/T024054\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["intestinalfailurejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Intestinal Failure"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.intf.2024.100007","type":"journal-article","created":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T11:11:16Z","timestamp":1721041876000},"page":"100007","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Anticoagulation and antiplatelet therapy in short bowel syndrome: A systematic review"],"prefix":"10.1016","volume":"1","author":[{"given":"Carolyn","family":"Mercer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J.","family":"Allan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Ambrose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.intf.2024.100007_bib1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.clnu.2014.08.017","article-title":"ESPEN endorsed recommendations. Definition and classification of intestinal failure in adults","volume":"34","author":"Pironi","year":"2015","journal-title":"Clin Nutr"},{"key":"10.1016\/j.intf.2024.100007_bib2","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.thromres.2017.10.025","article-title":"Pharmacokinetics of dabigatran etexilate and rivaroxaban in patients with short bowel syndrome requiring parenteral nutrition: The PDER PAN study","volume":"160","author":"Cheung","year":"2017","journal-title":"Thromb Res"},{"issue":"2","key":"10.1016\/j.intf.2024.100007_bib3","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1055\/s-0035-1544231","article-title":"Pros and cons of vitamin K antagonists and non-vitamin K antagonist oral anticoagulants","volume":"41","author":"Riva","year":"2015","journal-title":"Semin Thromb Hemost"},{"issue":"14","key":"10.1016\/j.intf.2024.100007_bib4","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.intf.2024.100007_bib5","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1002\/onco.13584","article-title":"Treatment of cancer-associated venous thromboembolism with low-molecular-weight heparin or direct oral anticoagulants: patient selection, controversies, and caveats","volume":"26","author":"O'Connell","year":"2021","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.intf.2024.100007_bib6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/1358863x07087730","article-title":"Sublingual administration of warfarin: a novel form of delivery","volume":"13","author":"Batke-Hastings","year":"2008","journal-title":"Vasc Med"},{"issue":"2 Suppl","key":"10.1016\/j.intf.2024.100007_bib7","first-page":"e24S","article-title":"Parenteral anticoagulants: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of","volume":"141","author":"Garcia","year":"2012","journal-title":"Chest Physicians Evid-Based Clin Pract Guidel Chest"},{"issue":"2","key":"10.1016\/j.intf.2024.100007_bib8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/bjs.4809","article-title":"Effect of low molecular weight heparin (dalteparin) and fondaparinux (Arixtra) on human osteoblasts in vitro","volume":"92","author":"Handschin","year":"2005","journal-title":"Br J Surg"},{"issue":"4","key":"10.1016\/j.intf.2024.100007_bib9","first-page":"369","article-title":"Anticoagulants for the prevention and treatment of catheter-related thrombosis in adults and children on parenteral nutrition: a systematic review and critical appraisal","volume":"15","author":"Barco","year":"2017","journal-title":"Blood Transfus"},{"key":"10.1016\/j.intf.2024.100007_bib10","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1182\/asheducation-2013.1.464","article-title":"Pros and cons of new oral anticoagulants","volume":"2013","author":"Bauer","year":"2013","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"11","key":"10.1016\/j.intf.2024.100007_bib11","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/psp4.12347","article-title":"Population Pharmacokinetics of Apixaban in Subjects With Nonvalvular Atrial Fibrillation","volume":"7","author":"Cirincione","year":"2018","journal-title":"CPT Pharmacomet Syst Pharm"},{"issue":"5","key":"10.1016\/j.intf.2024.100007_bib12","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1177\/0091270005274550","article-title":"Pharmacokinetic profile of the oral direct thrombin inhibitor dabigatran etexilate in healthy volunteers and patients undergoing total hip replacement","volume":"45","author":"Stangier","year":"2005","journal-title":"J Clin Pharm"},{"issue":"1","key":"10.1016\/j.intf.2024.100007_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40262-013-0100-7","article-title":"Clinical pharmacokinetic and pharmacodynamic profile of rivaroxaban","volume":"53","author":"Mueck","year":"2014","journal-title":"Clin Pharm"},{"issue":"5","key":"10.1016\/j.intf.2024.100007_bib14","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.amjmed.2016.12.033","article-title":"Oral Anticoagulant Use After Bariatric Surgery: A Literature Review and Clinical Guidance","volume":"130","author":"Martin","year":"2017","journal-title":"Am J Med"},{"issue":"12","key":"10.1016\/j.intf.2024.100007_bib15","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1111\/j.1538-7836.2007.02775.x","article-title":"Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel","volume":"5","author":"Brandt","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.intf.2024.100007_bib16","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.intf.2024.100007_bib17","first-page":"171","article-title":"Successful oral anticoagulant therapy in a patient with short bowel syndrome","volume":"34","author":"Mitchell","year":"1977","journal-title":"Am J Hosp Pharm"},{"issue":"3","key":"10.1016\/j.intf.2024.100007_bib18","first-page":"325","article-title":"Warfarin absorption in a patient with short-bowel syndrome","volume":"4","author":"Lehman","year":"1985","journal-title":"Clin Pharm"},{"issue":"2","key":"10.1016\/j.intf.2024.100007_bib19","first-page":"99","article-title":"Warfarin absorption after massive small bowel resection","volume":"80","author":"Lutomski","year":"1985","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.intf.2024.100007_bib20","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1177\/0148607187011003316","article-title":"Warfarin resistance associated with intravenous lipid administration. JPEN","volume":"11","author":"Lutomski","year":"1987","journal-title":"J Parent Enter Nutr"},{"issue":"1","key":"10.1016\/j.intf.2024.100007_bib21","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/0148607186010001100","article-title":"Bioavailability of warfarin in a patient with severe short bowel syndrome. JPEN","volume":"10","author":"Kearns","year":"1986","journal-title":"J Parent Enter Nutr"},{"issue":"6","key":"10.1016\/j.intf.2024.100007_bib22","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1177\/106002809002400605","article-title":"Oral anticoagulation in patients with short-bowel syndrome","volume":"24","author":"Owens","year":"1990","journal-title":"DICP"},{"issue":"2","key":"10.1016\/j.intf.2024.100007_bib23","first-page":"369","article-title":"When warfarin is not enough","volume":"58","author":"Lopez","year":"2010","journal-title":"J Invest Med"},{"issue":"Supplement 1","key":"10.1016\/j.intf.2024.100007_bib24","first-page":"132","article-title":"Warfarin is well absorbed from gastric mucosa alone in patients with extensive bowel resection: A case report of a patient with ultrashort bowel syndrome following portal and superior mesenteric vein thrombosis and antiphospholipid syndrome","volume":"185","author":"Khakwani","year":"2019","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.intf.2024.100007_bib25","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/8755122518808291","article-title":"Warfarin Absorption in Short Bowel Syndrome","volume":"35","author":"Quintal","year":"2019","journal-title":"J Pharm Technol"},{"issue":"1","key":"10.1016\/j.intf.2024.100007_bib26","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1177\/0148607187011001102","article-title":"Oral anticoagulant therapy in patients who require nutritional support. JPEN","volume":"11","author":"Gimmon","year":"1987","journal-title":"J Parent Enter Nutr"},{"issue":"5","key":"10.1016\/j.intf.2024.100007_bib27","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1024\/0301-1526\/a001018","article-title":"Quality of warfarin anticoagulation in adults with short bowel syndrome on home parenteral nutrition","volume":"51","author":"Fumagalli","year":"2022","journal-title":"Vasa"},{"issue":"Suppl 1","key":"10.1016\/j.intf.2024.100007_bib28","first-page":"128","article-title":"Successful liquid warfarin therapy in a patient with short bowel syndrome","volume":"201","author":"Theodoulou","year":"2023","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.intf.2024.100007_bib29","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/j.1875-9114.1998.tb03129.x","article-title":"Warfarin resistance in a patient with short bowel syndrome","volume":"18","author":"Brophy","year":"1998","journal-title":"Pharmacotherapy"},{"issue":"9","key":"10.1016\/j.intf.2024.100007_bib30","first-page":"208","article-title":"Warfarin resistance in a patient with short-bowel syndrome","volume":"45","year":"1987","journal-title":"Nutr Rev Jul"},{"issue":"2","key":"10.1016\/j.intf.2024.100007_bib31","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s12185-010-0508-x","article-title":"Monitoring plasma heparin concentration in a patient with antiphospholipid syndrome","volume":"91","author":"Inaba","year":"2010","journal-title":"Int J Hematol"},{"issue":"10","key":"10.1016\/j.intf.2024.100007_bib32","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s40262-019-00775-z","article-title":"Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic Review","volume":"58","author":"Byon","year":"2019","journal-title":"Clin Pharm"},{"issue":"7","key":"10.1016\/j.intf.2024.100007_bib33","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/jcph.1097","article-title":"Regional Gastrointestinal Absorption of Apixaban in Healthy Subjects","volume":"58","author":"Byon","year":"2018","journal-title":"J Clin Pharm"},{"issue":"2","key":"10.1016\/j.intf.2024.100007_bib34","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1365-2125.2012.04369.x","article-title":"Apixaban, an oral, direct factor Xa inhibitor: single dose safety, pharmacokinetics, pharmacodynamics and food effect in healthy subjects","volume":"75","author":"Frost","year":"2013","journal-title":"Br J Clin Pharm"},{"issue":"3","key":"10.1016\/j.intf.2024.100007_bib35","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s11239-016-1465-x","article-title":"Effect of major gastrointestinal tract surgery on the absorption and efficacy of direct acting oral anticoagulants (DOACs)","volume":"43","author":"Hakeam","year":"2017","journal-title":"J Thromb Thrombolysis"},{"issue":"5","key":"10.1016\/j.intf.2024.100007_bib36","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/bcp.12106","article-title":"Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor Xa inhibitor, in healthy subjects","volume":"76","author":"Frost","year":"2013","journal-title":"Br J Clin Pharm"},{"issue":"5","key":"10.1016\/j.intf.2024.100007_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.647","article-title":"Drug interactions with apixaban: A systematic review of the literature and an analysis of VigiBase, the World Health Organization database of spontaneous safety reports","volume":"8","author":"Fernandez","year":"2020","journal-title":"Pharm Res Perspect"},{"issue":"3","key":"10.1016\/j.intf.2024.100007_bib38","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.cjca.2017.12.021","article-title":"Personalized Anticoagulation: Guided Apixaban Dose Adjustment to Compensate for Pharmacokinetic Abnormalities Related to Short-Bowel Syndrome","volume":"34","author":"Pollak","year":"2018","journal-title":"Can J Cardiol"},{"issue":"5","key":"10.1016\/j.intf.2024.100007_bib39","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1177\/0091270006286904","article-title":"Effect of food, an antacid, and the H2 antagonist ranitidine on the absorption of BAY 59-7939 (rivaroxaban), an oral, direct factor Xa inhibitor, in healthy subjects","volume":"46","author":"Kubitza","year":"2006","journal-title":"J Clin Pharm"},{"issue":"11","key":"10.1016\/j.intf.2024.100007_bib40","first-page":"1478","article-title":"Pharmacokinetic and pharmacodynamic drug interactions with new oral anticoagulants: what do they mean for patients with atrial fibrillation?","volume":"47","author":"Hellwig","year":"2013","journal-title":"Ann Pharm"},{"issue":"6","key":"10.1016\/j.intf.2024.100007_bib41","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/FJC.0b013e31822f6c2b","article-title":"Effect of multiple doses of omeprazole on the pharmacokinetics, pharmacodynamics, and safety of a single dose of rivaroxaban","volume":"58","author":"Moore","year":"2011","journal-title":"J Cardiovasc Pharm"},{"issue":"2","key":"10.1016\/j.intf.2024.100007_bib42","first-page":"419","article-title":"Insufficient anticoagulation with dabigatran in a patient with short bowel syndrome","volume":"112","author":"Douros","year":"2014","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1016\/j.intf.2024.100007_bib43","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.thromres.2015.01.005","article-title":"Rivaroxaban as anticoagulant therapy in short bowel syndrome. Report of three cases","volume":"135","author":"Christensen","year":"2015","journal-title":"Thromb Res"},{"issue":"3","key":"10.1016\/j.intf.2024.100007_bib44","first-page":"453","article-title":"Population pharmacokinetics and pharmacodynamics of once- and twice-daily rivaroxaban for the prevention of venous thromboembolism in patients undergoing total hip replacement","volume":"100","author":"Mueck","year":"2008","journal-title":"Thromb Haemost"},{"issue":"Supplement 1","key":"10.1016\/j.intf.2024.100007_bib45","first-page":"862","article-title":"Interim analysis-safety and efficacy of rivaroxaban in a patient population with short bowel syndrome; a prospective observational cohort study","volume":"3","author":"Bavalia","year":"2019","journal-title":"Res Pract Thromb Haemost"},{"issue":"Suppl 1","key":"10.1016\/j.intf.2024.100007_bib46","article-title":"Rivaroxaban in patients with intestinal failure on parenteral nutrition (TINCRBEL study)","volume":"6","author":"van Haaps","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"issue":"10","key":"10.1016\/j.intf.2024.100007_bib47","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1161\/ATVBAHA.110.203604","article-title":"Dabigatran: an oral novel potent reversible nonpeptide inhibitor of thrombin","volume":"30","author":"Eisert","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"10.1016\/j.intf.2024.100007_bib48","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2165\/00003088-200847050-00001","article-title":"Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate","volume":"47","author":"Stangier","year":"2008","journal-title":"Clin Pharm"},{"issue":"12","key":"10.1016\/j.intf.2024.100007_bib49","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.intf.2024.100007_bib50","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.CIR.101.10.1206","article-title":"Aspirin","volume":"101","author":"Awtry","year":"2000","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.intf.2024.100007_bib51","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11239-011-0667-5","article-title":"P2Y12 platelet inhibition in clinical practice","volume":"33","author":"Damman","year":"2012","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.intf.2024.100007_bib52","article-title":"Individualised dual antiplatelet therapy in a patient with short bowel syndrome after acute myocardial infarction with coronary artery stenting","volume":"2015","author":"Droppa","year":"2015","journal-title":"BMJ Case Rep"},{"issue":"15","key":"10.1016\/j.intf.2024.100007_bib53","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1007\/s40265-013-0126-z","article-title":"Pharmacology of the new P2Y12 receptor inhibitors: insights on pharmacokinetic and pharmacodynamic properties","volume":"73","author":"Ferri","year":"2013","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.intf.2024.100007_bib54","first-page":"705","article-title":"Absorption and efficacy of acetylsalicylic acid in patients with short bowel syndrome","volume":"48","author":"Faye","year":"2014","journal-title":"Ann Pharm"},{"issue":"14","key":"10.1016\/j.intf.2024.100007_bib55","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1093\/eurheartj\/ehm226","article-title":"A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease","volume":"28","author":"Lordkipanidze","year":"2007","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.intf.2024.100007_bib56","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1160\/TH10-02-0082","article-title":"24-hour time-dependent aspirin efficacy in patients with stable coronary artery disease","volume":"105","author":"Henry","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.intf.2024.100007_bib57","article-title":"Short bowel syndrome and clopidogrel non-responsiveness: a new indication for platelet aggregometry?","volume":"2014","author":"Hadley","year":"2014","journal-title":"BMJ Case Rep"},{"issue":"1","key":"10.1016\/j.intf.2024.100007_bib58","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/ijlh.12937","article-title":"Comparison of light transmission aggregometry and multiple electrode aggregometry for the evaluation of patients with mucocutaneous bleeding","volume":"41","author":"Sun","year":"2019","journal-title":"Int J Lab Hematol"},{"issue":"12","key":"10.1016\/j.intf.2024.100007_bib59","first-page":"1347","article-title":"Effect of Short Bowel Syndrome on Ticagrelor Inhibition of Platelet Aggregation Post Percutaneous Coronary Intervention (PCI): A Case Report","volume":"5","author":"Allen","year":"2022","journal-title":"JACCP J Am Coll Clin Pharm"},{"issue":"6","key":"10.1016\/j.intf.2024.100007_bib60","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1182\/blood-2017-03-742338","article-title":"How I use laboratory monitoring of antiplatelet therapy","volume":"130","author":"Michelson","year":"2017","journal-title":"Blood"}],"container-title":["Intestinal Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950456224000071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950456224000071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T01:08:30Z","timestamp":1745024910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950456224000071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":60,"alternative-id":["S2950456224000071"],"URL":"https:\/\/doi.org\/10.1016\/j.intf.2024.100007","relation":{},"ISSN":["2950-4562"],"issn-type":[{"value":"2950-4562","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anticoagulation and antiplatelet therapy in short bowel syndrome: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Intestinal Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intf.2024.100007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of International Intestinal Rehabilitation & Transplant Association.","name":"copyright","label":"Copyright"}],"article-number":"100007"}}